Jpmorgan Chase & Co »

Revance Therapeutics Inc call shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Revance Therapeutics Inc call shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Revance Therapeutics Inc call

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics Inc call held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics Inc call by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $21k 2.4k 8.79
2023-09-30 $28k 2.4k 11.47
2023-03-31 $52k 1.6k 32.50
2022-06-30 $973k 70k 13.82
2022-03-31 $4.2M 217k 19.50
2021-12-31 $3.1M 192k 16.32

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Revance Therapeutics Inc call

Simplex Trading
Jane Street
Jpmorgan Chase & Co

View all funds holding Revance Therapeutics Inc call